Hims & Hers Health (HIMS) Gross Margin (2020 - 2026)
Hims & Hers Health (HIMS) reported Gross Margin of 65.25% for Q1 2026, down 825.0% on a YoY basis from 9.0% in Q1 2025, and down 9.29% sequentially from 71.94% in Q4 2025.
Hims & Hers Health (HIMS) Gross Margin (2020 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 7 years of Gross Margin data on file, last reported at 65.25% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin fell 825.0% year-over-year to 65.25%; the trailing twelve-month figure through Mar 2026 stood at 71.72% (down 533.0% YoY), and the FY2025 full-year result was 73.84%, down 562.0% from the prior year.
- Gross Margin retreated to 65.25% in Q1 2026, from 71.94% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 82.74% in Q4 2023 to a low of 65.25% in Q1 2026.
- A 5-year average of 77.46% and a median of 79.02% in 2022 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin jumped 664 bps in 2023 and tumbled 886 bps in 2025, its largest moves.
- Tracing HIMS's Gross Margin over 5 years: stood at 79.15% in 2022, then climbed by 5 bps to 82.74% in 2023, then decreased by 7 bps to 76.81% in 2024, then slipped by 6 bps to 71.94% in 2025, then retreated by 9 bps to 65.25% in 2026.
- Business Quant data shows HIMS's Gross Margin at 65.25% in Q1 2026, 71.94% in Q4 2025, and 73.8% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 49.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 71.66% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 62.93% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 82.93% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.97% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 98.31% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.26% |
| 10 | Hims & Hers Health | 7.48 Bn | 6.73 Bn | 396.79 Mn | 65.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.25% |
| Dec 31, 2025 | 71.94% |
| Sep 30, 2025 | 73.80% |
| Jun 30, 2025 | 76.39% |
| Mar 31, 2025 | 73.50% |
| Dec 31, 2024 | 76.81% |
| Sep 30, 2024 | 79.16% |
| Jun 30, 2024 | 81.30% |
| Mar 31, 2024 | 82.36% |
| Dec 31, 2023 | 82.74% |
| Sep 30, 2023 | 82.62% |
| Jun 30, 2023 | 81.84% |
| Mar 31, 2023 | 80.42% |
| Dec 31, 2022 | 79.15% |
| Sep 30, 2022 | 79.02% |
| Jun 30, 2022 | 76.76% |
| Mar 31, 2022 | 73.79% |
| Dec 31, 2021 | 73.32% |
| Sep 30, 2021 | 73.98% |
| Jun 30, 2021 | 77.90% |